Landscapes / Companies

Xuanzhu Biopharmaceutical Co., Ltd. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
On the market
Next date
KM501, Phase 1 trial completes
Drugs
7
in active trials · 10 in all
Trials
11 active
24 since 2021

Drugs7

DrugHow it worksPartnerStageNext dateDetails
Anaprazolenot checked
Antiulcer, benzimidazole derivative
On the market 19 Feb 2027Phase 3 trial completes
—
Phase 3 —
—
Phase 1/2 —
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —
—
SignalChem Lifesciences Corporation
Phase 1 —

About

No active trial
XZP-3621, XZP-5610, XZP-6019
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Xuanzhu Biopharmaceutical Co., Ltd.

Following is part of Solo: you see every change to Xuanzhu Biopharmaceutical Co., Ltd. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in